Personalized Medicine and the Affordable Care ActVideo Categories: Affordable Care Act
Personalized Medicine and the Impact on the Pharmaceutical Company
Dr Agarwala hypothesizes how the future of the traditional pharmaceutical company may change with the developments in personalized medicine.
The Impact of Hedgehog Pathway Inhibitors on the Management of Patients with Basal Cell Carcinoma
In this third WCMC clinical commentary entitled, Basal Cell Carcinoma Case Studies in Hedgehog Pathway Inhibition Radiation, Joel Claveau, MD, CSPQ, FRCPC; Dirk Schadendorf, MD; Nicole Basset-Seguin, MD, PhD and Aleksandar Sekulic, MD, PhD discuss different case studies where patients were successfully treated by Hedgehog Pathway Inhibitors.